
Alona Zer
@zeralona
Head, Department of Medical Oncology @RambamHCC Technion University - thoracic oncology & sarcoma ๐ณ๏ธโ๐๐ฎ๐ฑ
ID: 1089966370870214659
28-01-2019 19:20:08
407 Tweet
596 Followers
310 Following

Thank you Marco Tagliamento Martin Reck Daniel Tan and Michal Lotem for a wonderful session & for demonstrating how wide is the world of IO beyond PD1 blockade #ELCC24


Best motivations for attending meetings is to catch up with #colleagues, #friends, #collaborators & #twitterpals from around the ๐. Many a times these in corridor โhellosโ are brief, but itโs always great to keep in touch! #ELCC24 Alfredo Addeo MD Mark Awad Vamsi Velcheti, MD MBA FASCO


Last day and last hour of #ELCC2024 - this conference keeps delivering: โฆLizza Hendriksโฉ gives a comprehensive review on systemic therapy for CNS metastases ๐ง โฆESMO - Eur. Oncologyโฉ


25 Posts Not To Miss From ELCC 2024 oncodaily.com/41993.html Dr. Antonio Calles ๐ซ๐ญ Giannis Mountzios Stephen V Liu, MD Julien Mazieres Alfredo Addeo MD Jennifer C. King, PhD @esinghimd Mariana Brandao Charu Aggarwal, MD, MPH, FASCO Gerry Hanna Xiuning Le MD PhD Alona Zer giuseppe viscardi Noemi Reguart Jarushka Naidoo Cecilia Pompili MD PhD FACS #OncoDaily


The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Sarcoma Service at Memorial Sloan Kettering sciencedirect.com/science/articlโฆ

In this #ASCO Educational Book๐ we summarize in EGFR mut๐ซ: โ๏ธNew EGFR TKI options in early stage โ๏ธNew options in metastatic setting โ๏ธMechanisms of acquired resistance and new drugs ๐งฌ online at ascopubs.org/journal/edbk Thanks to Stephanie Saw Xiuning Le MD PhD Lizza Hendriks


ืืืืืช ืืืืข ืืืื ืื ืืืืฉืืื- ืืฉ ืื ื ืืื ื ืืืืืจืืช ืืืืื ืืขืืื ืืืืืช ืืกืืื ืืฉืืื- ืืจืื ื ืขืืื ืืฆืื ื ืืืจืืช ืืืื ืืคืืจืฉ ืืืืจืื ืืืืืช ื'ื ืืืืื- ืืฉ ืื ื ืื ืืื ืืืืื ืืฆืืื ืืืืืช ืืื ืืืืืืจ ืืฆื"ื- ืื ืื ื ืืกืืืืื ืืืื ืขื ืขืฆืื ื ืืื ืืืืจืื ืฉืืืืืื ืืืคื ืคื ืืฆืืจื ืงืืืื






Brilliantly discussed by Stephen V Liu, MD both SCLC abstracts: subgroup analysis of ADRIATIC and anti-flucosyl-GM1 #ESMO24 #LCSM


In Barcelona for #ESMO24 for just a few hours and already some great scientific discussions plus met with such wonderful thoracic oncology experts from around the world! #ESMOAmbassadors Fiona Blackhall Cecilia Pompili MD PhD FACS Alona Zer Chiara CATANIA


At the Palau Nacional for the #ESMO24 Presidential Dinner with Thoracic Oncology royalty! Solange Peters Enriqueta Felip Pilar Garrido Aษดแดแดษดษชแด Pแดssแดสแด Dr. Antonio Calles ๐ซ๐ญ @ArielleElkrief @BertrandRouty Ticiana Batista (Leal) Cecilia Pompili MD PhD FACS Isabelle Opitz Heather Wakelee Alona Zer #ESMOAmbassadors



Send your applications! Unique opportunity for career mentoring in thoracic onc IASLC Great team! Rami Manochakian MD, FASCO Cancer Education Karen Kelly Marina Garassino Dr. Amy C. Moore Anne Tsao, MD, MBA Jyoti D Patel LudaBazhenovaMD Balazs Halmos Dr. Luis E. Raez Triparna Sen (Sen-Lab) Jonathan Spicer MD PhD Alona Zer Pilar Garrido



Israel launched a defensive and preemptive strike against Iranโs nuclear operations. Hereโs what we know so far. Israel targeted Iranโs nuclear sites, their ballistic missile programs, nuclear infrastructure, engineers, and nuclear scientists, and its top military commanders,